Quick Dispatch:
Your lilly direct tirzepatide Zepbound is about to get WAY more affordable. Starting July 7, Lilly is expanding access to all approved doses of Zepbound (tirzepatide) through LillyDirect's Self Pay Program — no insurance needed. Now orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your lilly direct tirzepatide Zepbound is about to get WAY more affordable. Starting July 7, Lilly is expanding access to all approved doses of Zepbound (tirzepatide) through LillyDirect's Self Pay Program — no insurance needed. Now ships.
Need Help?
Questions about lilly direct tirzepatide Zepbound is about to get WAY more affordable. Starting July 7, Lilly is expanding access to all approved doses of Zepbound (tirzepatide) through LillyDirect's Self Pay Program — no insurance needed. Now, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for lilly direct tirzepatide Zepbound is about to get WAY more affordable. Starting July 7, Lilly is expanding access to all approved doses of Zepbound (tirzepatide) through LillyDirect's Self Pay Program — no insurance needed. Now in your area.
Zepbound Vials Online | Zepbound Vials for Weight Loss
24.19
https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound
21.19
Zepbound Now Available Through LillyDirect: A New Option for Tirzepatide Access at a Predictable Price
27.16
Lilly Updates Open Letter Regarding the Use of Tirzepatide for Cosmetic Weight Loss
23.82
Eli Lilly's Zepbound to be issued in single-dose vials for self-payers
28.41
Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, tirzepatide (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can
24.93
Eli Lilly Launches Self-Pay Vials of Tirzepatide for Patients With Obesity
24.16
